Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Droxidopa
Droxidopa
23651-95-8
|
213.064
|
-2.484
Droxidopa is used in the treatment of Parkinsonism. Droxidopa crosses the blood-brain barrier where it is converted to norepinephrine via decarboxylation by L-aromatic-amino-acid decarboxylase. Norephinephrine acts at alpha-adrenergic receptors as a vasoconstrictor and at beta-adrenergic receptors as a heart stimulator and artery dilator.
L-threo-3,4-dihydroxyphenylserine | droxidopa | threo-3-(3,4-dihydroxyphenyl)-L-serine
Droxidopa is used in the treatment of Parkinsonism. Droxidopa crosses the blood-brain barrier where it is converted to norepinephrine via decarboxylation by L-aromatic-amino-acid decarboxylase. Norephinephrine acts at alpha-adrenergic receptors as a vasoconstrictor and at beta-adrenergic receptors as a heart stimulator and artery dilator.
L-threo-3,4-dihydroxyphenylserine | droxidopa | threo-3-(3,4-dihydroxyphenyl)-L-serine
$240/5 mg
(EBC)
1
We provide 0 compound for Droxidopa